Print

Leading Nanomedicine Firm Nanobiotix Successfully Closes Its $ 11 Million Series-C Financing Round  
5/3/2010 10:07:08 AM

PARIS--(BUSINESS WIRE)--Nanobiotix, based in Paris, France, announces the closing of a $ 11 million series-C financing round. The company develops innovative therapeutic products for cancer using nanotechnologies.
//-->